Evidence map›Paper›PMID 33670102›Full record

ArticleMetabolites2021

Ranking Metabolite Sets by Their Activity Levels.

Karen McLuskey, Joe Wandy, Isabel Vincent, Justin J J van der Hooft, Simon Rogers, Karl Burgess, Rónán Daly

Abstract read
In one paragraph

Article in Metabolites, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Karen McLuskeyGlasgow Polyomics, University of Glasgow, Glasgow G61 1QH, UK.ORCID 0000-0002-9841-4943
Joe WandyGlasgow Polyomics, University of Glasgow, Glasgow G61 1QH, UK.ORCID 0000-0002-3068-4664
Isabel VincentIBioIC, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G1 1XQ, UK.ORCID 0000-0003-2663-4389
Justin J J van der HooftBioinformatics Group, Wageningen University, 6708 PB Wageningen, The Netherlands.ORCID 0000-0002-9340-5511
Simon RogersSchool of Computing Science, University of Glasgow, Glasgow G12 8QQ, UK.ORCID 0000-0003-3578-4477
Karl BurgessCentre for Synthetic and Systems Biology, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3JG, UK.ORCID 0000-0002-0881-715X
Rónán DalyGlasgow Polyomics, University of Glasgow, Glasgow G61 1QH, UK.ORCID 0000-0002-1275-6820

Funding

Innovate UK 102511Netherlands eScience Center ASDI.2017.030Wellcome Trust 105614/Z/14/Z
6 · The paper itself

Abstract

Related metabolites can be grouped into sets in many ways, e.g., by their participation in series of chemical reactions (forming metabolic pathways), or based on fragmentation spectral similarities or shared chemical substructures. Understanding how such metabolite sets change in relation to experimental factors can be incredibly useful in the interpretation and understanding of complex metabolomics data sets. However, many of the available tools that are used to perform this analysis are not entirely suitable for the analysis of untargeted metabolomics measurements. Here, we present PALS (Pathway Activity Level Scoring), a Python library, command line tool, and Web application that performs the ranking of significantly changing metabolite sets over different experimental conditions. The main algorithm in PALS is based on the pathway level analysis of gene expression (PLAGE) factorisation method and is denoted as mPLAGE (PLAGE for metabolomics). As an example of an application, PALS is used to analyse metabolites grouped as metabolic pathways and by shared tandem mass spectrometry fragmentation patterns. A comparison of mPLAGE with two other commonly used methods (overrepresentation analysis (ORA) and gene set enrichment analysis (GSEA)) is also given and reveals that mPLAGE is more robust to missing features and noisy data than the alternatives. As further examples, PALS is also applied to human African trypanosomiasis, Rhamnaceae, and American Gut Project data. In addition, normalisation can have a significant impact on pathway analysis results, and PALS offers a framework to further investigate this. PALS is freely available from our project Web site.

Indexed as

liquid chromatography–mass spectrometry (LC/MS)Mass2Motifmatrix decompositionmetabolite setsmolecular familypathwaysSVD

Identifiers

PMID33670102
PMCPMC7916825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.